Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2013
11/06/2013CN101637531B Application of Chinese medicinal composition in preparation of medicament for treating acute nephritis
11/06/2013CN101611005B Substituted acetophenones useful as PDE4 inhibitors
11/06/2013CN101484471B Anti-NKG2A antibodies and uses thereof
11/06/2013CN101460059B Compound for antimicrobial therapy for bacterial infections and its pharmaceutical uses
11/06/2013CN101448851B Improved antimicrobial peptides
11/06/2013CN101361723B Improved pharmaceutical compositions
11/06/2013CN101304987B Aminophenylsulfonamide derivatives as HIV protease inhibitor
11/06/2013CN101302515B Human antibodies that bind human TNF(alpha)
11/06/2013CN101273042B Macrocyclic inhibitors of hepatitis C virus
11/06/2013CN101267815B Metal-beta-lactamase inhibitor
11/06/2013CN101248084B Tuberculosis vaccines comprising antigens expressed during the latent infection phase
11/05/2013US8575340 Purine derivatives and their pharmaceutical uses
11/05/2013US8575204 Nicotinamide derivates useful as P38 inhibitors
11/05/2013US8575180 9-substituted 8-oxoadenine compound
11/05/2013US8575147 Spontaneously dispersible N-benzoyl staurosporine compositions
11/05/2013US8575118 Antiviral compounds
11/05/2013US8574634 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions
11/05/2013US8574599 Methods and products for inducing mucosal immunity
11/05/2013US8574565 Pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes
11/05/2013US8574563 Hepatitis C virus inhibitors
11/05/2013CA2672722C Methods of preparing substituted tetracyclines with transition metal-based chemistries
11/05/2013CA2512673C 2-o sulfatase compositions and related methods
11/05/2013CA2461305C Methods of suppressing microglial activation and systemic inflammatory responses
11/05/2013CA2341037C Bioactive peptides
11/05/2013CA2328403C Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis
10/2013
10/31/2013WO2013163509A1 A method of mitigating virus associated end-organ damage
10/31/2013WO2013163508A1 Tetrahydropyran dgat1 inhibitors
10/31/2013WO2013163427A1 Antibodies to treat hiv-1 infection
10/31/2013WO2013163422A1 Growth factors for the treatment of mycobacterial infection
10/31/2013WO2013163404A1 TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
10/31/2013WO2013163270A1 Hepatitis c virus inhibitors
10/31/2013WO2013163210A1 Method and system for detection of an organism
10/31/2013WO2013162771A1 Lectin conjugates for mucin hydration
10/31/2013WO2013162751A1 Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
10/31/2013WO2013162746A1 Staphylococcal coagulase antigens and methods of their use
10/31/2013WO2013162742A1 Methods and compositions for treatment of multidrug-resistant bacterial and fungal infections
10/31/2013WO2013162350A2 Circular antiviral rna
10/31/2013WO2013162078A1 Therapeutic agent for injury in epithelium and endothelium
10/31/2013WO2013162050A1 Lactoferrin fusion protein and method for producing same
10/31/2013WO2013162016A1 New carbamate glycolipid and use thereof
10/31/2013WO2013161933A1 Deuterated nitrogen-containing heterocyclic carboxamide derivative
10/31/2013WO2013161871A1 Thiophene derivative having tlr-inhibiting activity
10/31/2013WO2013161408A1 Method for inducing t cell differentiation, method for producing t cells, t cells, pharmaceutical composition, and screening method
10/31/2013WO2013161327A1 Sterilization treatment method, preparation for sterilization use, frozen body for sterilization use and method and apparatus for producing same, and method for producing liquid for sterilization use
10/31/2013WO2013160913A1 Rotavirus vaccine compositions and process for preparing the same
10/31/2013WO2013160670A1 Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex
10/31/2013WO2013160505A1 Method for producing a vital-organ-regenerative product and by-product for cutaneous use
10/31/2013WO2013160435A1 Antibacterial quinoline derivatives
10/31/2013WO2013160431A1 Antibacterial quinoline derivatives
10/31/2013WO2013159243A1 Compositions and uses of functional receptor for hbv/hdv virus
10/31/2013WO2013159234A1 Glycoengineered outer membrane vesicles and use thereof as vaccines
10/31/2013WO2013134047A3 Aminoquinoline derivatives and uses thereof
10/31/2013WO2013108105A3 Novel solvates of darunavir
10/31/2013WO2004061073A9 Novel human proteins, polynucleotides encoding them and methods of using the same
10/31/2013WO2003023014A9 Human ion channels
10/31/2013US20130289104 Aliphatic amino acid biosynthesis inhibitors and a method of synthesizing the same
10/31/2013US20130287725 Biocompatible polymers, process for their preparation and compositions containing them
10/31/2013US20130287724 Anti-adherent formulation including an anionic or nonionic polymer
10/31/2013US20130287712 Foaming formulations including silicone-based polyurethanes
10/30/2013EP2657333A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
10/30/2013EP2657241A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
10/30/2013EP2657235A1 Compound containing basic group and use thereof
10/30/2013EP2657234A1 Optically-active diazabicyclooctane derivative and method for manufacturing same
10/30/2013EP2657231A2 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
10/30/2013EP2656879A1 Transdermal delivery systems of beta-lactam antibiotics
10/30/2013EP2656846A1 Phosphomycin pharmaceutical composition
10/30/2013EP2655613A1 Virus like particle production in plants
10/30/2013EP2655603A2 Novel bacteriophage and antibacterial composition comprising the same
10/30/2013EP2655392A1 Cyclic nucleotide analogs
10/30/2013EP2655389A2 Compounds
10/30/2013EP2655362A1 Hepatitis c inhibitors and uses thereof
10/30/2013EP2654900A1 Combinations for treating hcv
10/30/2013EP2654756A1 Compound having antibacterial activity
10/30/2013EP2654753A1 Sanglifehrin derivatives and methods for their production
10/30/2013EP2654746A1 Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
10/30/2013CN103380146A Lipidated polyepitope vaccines
10/30/2013CN103380141A Novel macrolide derivative
10/30/2013CN103380132A Phenanthridine macrocyclic hepatitis c serine protease inhibitors
10/30/2013CN103380115A Sulfur derivatives as chemokine receptor modulators
10/30/2013CN103380108A Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups
10/30/2013CN103379918A Oral composition and method of forming and using same
10/30/2013CN103379916A Respiratory syncytial virus vaccine
10/30/2013CN103374580A Enterovirus 71 (EV 71) Fuyang strain and cDNA (deoxyribonucleic acid) infectious clone of attenuated strain of enterovirus 71 (EV 71) Fuyang strain as well as application of enterovirus 71 (EV 71) Fuyang strain
10/30/2013CN103374577A Sheep ISG (immune serum globulin) 15 recombinant protein as well as coding gene and application thereof
10/30/2013CN103374557A Mannose glycosylated lysozyme and application thereof
10/30/2013CN103374549A Novel EV71 virus strain and application thereof
10/30/2013CN103374547A Method for preparing purified foot-and-mouth disease vaccine
10/30/2013CN103374070A Anti-rabies-virus combination molecule 2F5
10/30/2013CN103374069A Anti-rabies-virus combination molecule 2E1
10/30/2013CN103374020A Naphthalene-ring containing thiazole [4, 5-b] quinoxaline derivatives and preparation methods thereof
10/30/2013CN103374014A Salt of chelidonine derivative
10/30/2013CN103374013A Salt of dihydrosanguinarine derivative
10/30/2013CN103374012A Salt of sanguinarine derivative
10/30/2013CN103374011A Salt of dihydro nitidine derivative
10/30/2013CN103374010A Salt of methoxy dihydronitidine derivate
10/30/2013CN103374009A Salt of nitidine derivative
10/30/2013CN103374008A Salt of chelerythrine derivative
10/30/2013CN103374007A Salt of dihydrochelerythrine derivative
10/30/2013CN103374006A Natural medicament for inhibiting hepatitis virus
10/30/2013CN103373994A Therapeutic compounds
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 1798